Akhilesh Kumar Verma

Akhilesh Kumar Verma

Auto-generated profile, based on publicly available information

Akhilesh Kumar Verma

Department of Biochemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh 221005, India

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2014 in Journal of Clinical and Diagnostic Research
Verified
Journal Article
Open access
ABAshutosh Bajpai
Ashutosh Bajpai
AVAkhilesh Kumar Verma
Akhilesh Kumar Verma
MSMona Srivastava
Mona Srivastava
RSRagini Srivastava
Ragini Srivastava
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.

5 September 2012 in Platelets
Verified
Journal Article
Closed access
AGAshish Kumar Gupta
Ashish Kumar Gupta
AVAkhilesh Kumar Verma
Akhilesh Kumar Verma
JKJyotsna Kailashiya
Jyotsna Kailashiya
SSSurya Kumar Singh
Surya Kumar Singh
NKNarender Kumar
Narender Kumar
Sitagliptin, a selective dipeptidyl peptidase-4 inhibitor drug is used to treat type-2 diabetes (T2DM). We investigated the anti-platelet activity of sitagliptin in patients with T2DM and in in vitro samples obtained from healthy humans. Patients with T2DM (27 male + 23 female) were selected and followed up before (control) and after treatment with sitagliptin for up to 3 months. Platelets were isolated from the blood of sitagliptin treated patients and controls. Patients with T2DM treated with sitagliptin for 1and 3 months, showed 10 ± 2% and 30 ± 5% inhibition of platelet aggregation, respectively. For the in vitro study, platelets from 10 normal humans (n = 10) were isolated. Platelet aggregation, intracellular free calcium and tyrosine phosphorylation of multiple proteins were measured by aggregometer, spectrofluorometer and western blotting, respectively. Platelets pre-treated with 5 and 10 µg/ml of sitagliptin, showed 25 ± 4% and 40 ± 6% inhibition of thrombin-induced platelet aggregation, respectively. Sitagliptin decreased intracellular free calcium (2.5-fold) and tyrosine phosphorylation of multiple proteins in thrombin-induced platelet activation. Sitagliptin inhibited platelet aggregation in T2DM as well as in healthy humans. Sitagliptin has significant concentration-dependent anti-platelet activity. This activity was due to its inhibitory effect on intracellular free calcium and tyrosine phosphorylation.

8 September 2014 in Biochemistry Research International
Verified
Journal Article
Open access
PDF file
AVAkhilesh Kumar Verma
Akhilesh Kumar Verma
SCSubhash Chandra
Subhash Chandra
RSRana Gopal Singh
Rana Gopal Singh
TSTej Bali Singh
Tej Bali Singh
SSShalabh Srivastava
Shalabh Srivastava
RSRohit Srivastava
Rohit Srivastava
Association of oxidative stress and serum prolidase activity (SPA) has been reported in many chronic diseases. The study was aimed at evaluating the correlation of glucose and creatinine to SPA and oxidative stress in patients with diabetic nephropathy (DN) and end stage renal disease (ESRD) concerned with T2DM. 50 healthy volunteers, 50 patients with T2DM, 86 patients with DN, and 43 patients with ESRD were considered as control-1, control-2, case-1, and case-2, respectively. Blood glucose, creatinine, SPA, total oxidant status (TOS), total antioxidant status (TAS), and oxidative stress index (OSI) were measured by colorimetric tests. SPA, TOS, and OSI were significantly increased in case-1 and case-2 than control-1 and control-2, while TAS was significantly decreased(P<0.001). Blood glucose was linearly correlated to SPA, TOS, TAS, and OSI in control-2, case-1 and case-2(P<0.001). Serum creatinine was linearly correlated with SPA, TOS, TAS and OSI in control-2 and case-1(P<0.001). In case-2, serum creatinine was significantly correlated with SPA only(P<0.001). Thus, the study concluded that SPA and oxidative stress significantly correlated with blood glucose and creatinine. SPA, TOS, TAS, and OSI can be used as biomarkers for diagnosis of kidney damage.

9 August 2015 in Parkinson's Disease
Verified
Journal Article
Open access
PDF file
AVAkhilesh Kumar Verma
Akhilesh Kumar Verma
JRJanak Raj
Janak Raj
VSVivek Sharma
Vivek Sharma
TSTej Bali Singh
Tej Bali Singh
SSShalabh Srivastava
Shalabh Srivastava
RSRagini Srivastava
Ragini Srivastava
Prolidase deficiency has been related to mental retardation and oxidative stress. The study aimed to observe plasma prolidase activity (PPA), total oxidant status (TOS), total antioxidant status (TAS), and oxidative stress index (OSI) in patients with Parkinson’s disease (PD). 240 subjects with PD and 150 healthy volunteers were considered as cases and controls, respectively. PPA, TOS, TAS, and OSI were measured spectrophotometrically. PPA and TAS in cases were more significantly decreased than controls(P<0.01), while TOS and OSI were significantly increased(P<0.001). In cases, nonsignificant, positive correlation was observed between PPA and TOS and OSI while significant, negative correlation was observed between PPA and TAS(P=0.047). PPA in cases was nonsignificantly decreased with increased duration of PD(P=0.747)while TAS was significantly decreased(P<0.001)and TOS and OSI were significantly increased(P<0.001). It was observed that higher age groups had decreased PPA, and TAS and increased TOS and OSI compared to lower age groups in cases. In summary, patients with PD have decreased PPA and increased oxidative stress compared to healthy volunteers. PPA was associated with oxidative stress markers in patients with PD. Decreased PPA and TAS and increased TOS and OSI were associated with progression of disease and higher age.

14 September 2015 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
AVAkhilesh Kumar Verma
Akhilesh Kumar Verma
AKAnand Kumar Keshari
Anand Kumar Keshari
JRJanak Raj
Janak Raj
RKRenu Kumari
Renu Kumari
TKTarun Kumar
Tarun Kumar
RSRagini Srivastava
Ragini Srivastava

29 October 2013 in ISRN Biochemistry
Verified
Journal Article
Open access
PDF file
SKShweta Kumari
Shweta Kumari
AVAkhilesh Kumar Verma
Akhilesh Kumar Verma
SRSumit Rungta
Sumit Rungta
RMRahul Mitra
Rahul Mitra
RSRagini Srivastava
Ragini Srivastava
NKNarender Kumar
Narender Kumar
Helicobacter pylori (H. pylori)infection is associated with increased oxidative stress and serum prolidase activity (SPA) in many diseases. We aimed to observe SPA and oxidative stress in nonulcer dyspepsia (NUD) infected with and withoutH. pyloriamong eastern Indians. 106 patients withH. pyloripositive NUD, 82 patients withH. pylorinegative NUD, and 50 healthy individuals were selected. SPA, total antioxidant capacity (TAOC), and total oxidant status (TOS) were measured with the use of spectrophotometer and an automated measurement method. SPA, TOS, and oxidative stress index (OSI) were significantly higher in patients withH. pyloripositive thanH. pylorinegative NUD and healthy individuals (all ), whereas TAOC was significantly lower (). Nonsignificant, increased SPA ( value = 0.6083) and decreased TAOC ( value = 0.1186) were observed in patients withH. pylorinegative NUD than healthy individuals, while increased TOS and OSI were significant (). Weak, nonsignificant correlations were observed between serum prolidase activity and TAOC, TOS, and OSI inH. pyloripositive cases. Thus, increased SPA along with increased oxidative stress was observed, which seem to be closely associated withH. pyloriinfection. SPA and oxidative stress seem to be used as biomarkers forH. pyloriinfection in NUD.